Is a Second Wave coming?
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Am I immune to COVID-19 if I have antibodies?
UNC-Chapel Hill researchers create new type of COVID-19 antibody test
To help West Virginia reopen safely, WVU researchers develop new COVID-19 tests
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
Top Analyst Sees More Than One Path to COVID-19 Solutions for Sorrento
Coronavirus: how T cells are involved and what it might mean for vaccine development
Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Lilly COVID-19 treatment could be authorized for use as soon as September
AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment
A drug for the treatment of COVID-19 complications is registered in Russia
Top 10 most valuable pharma brands in the world
Sorrento’s COVID-19 Cocktail Could Drive Major Upside, Says Analyst
Upcoming Korean COVID-19 Vaccine Trial Marks Key Milestone for Inovio (INO); 5-Star Analyst Says 'Buy'
Calliditas hits $90m jackpot as biotech IPO craze continues
Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial
Sorrento Therapeutics and Mount Sinai Health System
Novavax Surging On $60M Funding For Covid-19 Vaccine Candidate
Intravacc Partners to Develop Intranasal COVID-19 Vaccine
Tyson the alpaca takes heavyweight role in search for coronavirus vaccine
5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed
3 "Strong Buy" Healthcare Stocks Under $5 With Big Upside Potential
Herd immunity in Europe – are we close?
Antibody injections could fight COVID-19 infections – an infectious disease expert explains the prospects
Can antibody tests tell us who is immune to COVID-19?
Lilly begins trial of COVID-19 antibody treatment
A better model for neutrophil-related diseases
Researchers map SARS-CoV-2 infection in cells of nasal cavity, bronchia, lungs
Moderna Embarks On Phase 2 Study Of Covid-19 Candidate; Shares Pop 11%